1.
Kota SK, Meher LK, Jammula S, Kota SK, Modi KD. ACE inhibitors or ARBs for diabetic
nephropathy: the unrelenting debate. Diabetes Metab Syndr. 2012;6(4):215-217.
2.
Keane WF, Brenner BM, de Zeeuw D, et al. The risk of developing end-stage renal disease in patients
with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 2003;63(4):1499-1507.
3.
Parving HH, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of
diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345(12):870-878.
4.
Tuttle KR, Cherney DZ, Diabetic Kidney Disease Task Force of the American Society of N. Sodium
Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease. Clin J Am
Soc Nephrol. 2020;15(2):285-288.
5.
Tuttle KR, Brosius FC, 3rd, Cavender MA, et al. SGLT2 Inhibition for CKD and Cardiovascular
Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney
Foundation. Am J Kidney Dis. 2021;77(1):94-109.
6.
Chander PN, Gealekman O, Brodsky SV, et al. Nephropathy in Zucker diabetic fat rat is associated
with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger
ebselen. J Am Soc Nephrol. 2004;15(9):2391-2403.
7.
Nangaku M, Izuhara Y, Usuda N, et al. In a type 2 diabetic nephropathy rat model, the improvement of
obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy.
Nephrol Dial Transplant. 2005;20(12):2661-2669.
8.
Zhao HJ, Wang S, Cheng H, et al. Endothelial nitric oxide synthase deficiency produces accelerated
nephropathy in diabetic mice. J Am Soc Nephrol. 2006;17(10):2664-2669.
9.
Mohan S, Reddick RL, Musi N, et al. Diabetic eNOS knockout mice develop distinct macro- and
microvascular complications. Lab Invest. 2008;88(5):515-528.
10.
Giani JF, Burghi V, Veiras LC, et al. Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker
diabetic fatty rats. Am J Physiol Renal Physiol. 2012;302(12):F1606-1615.
11.
Harlan SM, Heinz-Taheny KM, Sullivan JM, et al. Progressive Renal Disease Established by
Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models. J Am Soc
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
23 / 30
Nephrol. 2018;29(2):477-491.
12.
Rosenthal T, Younis F, Alter A. Combating Combination of Hypertension and Diabetes in Different Rat
Models. Pharmaceuticals. 2010;3(4):916-939.
13.
Tang M, Wei X, Wan X, Ding Z, Ding Y, Liu J. The role and relationship with efflux pump of biofilm
formation in Klebsiella pneumoniae. Microb Pathog. 2020;147:104244.
14.
Ishii Y, Ohta T, Sasase T, et al. Pathophysiological analysis of female Spontaneously Diabetic Torii
fatty rats. Exp Anim. 2010;59(1):73-84.
15.
Kemmochi Y, Fukui K, Maki M, et al. Metabolic Disorders and Diabetic Complications in
Spontaneously Diabetic Torii Lepr (fa) Rat: A New Obese Type 2 Diabetic Model. J Diabetes Res.
2013;2013:948257.
16.
Ohta T, Katsuda Y, Miyajima K, et al. Gender differences in metabolic disorders and related diseases in
Spontaneously Diabetic Torii-Lepr(fa) rats. J Diabetes Res. 2014;2014:841957.
17.
Katsuda Y, Sasase T, Tadaki H, et al. Contribution of hyperglycemia on diabetic complications in obese
type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin. Exp Anim. 2015;64(2):161-169.
18.
Toriniwa Y, Saito T, Miyajima K, et al. Investigation of pharmacological responses to anti-diabetic
drugs in female Spontaneously Diabetic Torii (SDT) fatty rats, a new nonalcoholic steatohepatitis
(NASH) model. J Vet Med Sci. 2018;80(6):878-885.
19.
Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities.
Clin J Am Soc Nephrol. 2017;12(12):2032-2045.
20.
Bayorh MA, Mann G, Walton M, Eatman D. Effects of enalapril, tempol, and eplerenone on
salt-induced hypertension in dahl salt-sensitive rats. Clin Exp Hypertens. 2006;28(2):121-132.
21.
Buss SJ, Backs J, Kreusser MM, et al. Spironolactone preserves cardiac norepinephrine reuptake in
salt-sensitive Dahl rats. Endocrinology. 2006;147(5):2526-2534.
22.
Cohen MP, Lautenslager GT, Shearman CW. Increased urinary type IV collagen marks the
development of glomerular pathology in diabetic d/db mice. Metabolism. 2001;50(12):1435-1440.
23.
Gartner K. Glomerular hyperfiltration during the onset of diabetes mellitus in two strains of diabetic
mice (c57bl/6j db/db and c57bl/ksj db/db). Diabetologia. 1978;15(1):59-63.
24.
Charytan DM, Forman JP. You are what you eat: dietary salt intake and renin-angiotensin blockade in
diabetic nephropathy. Kidney Int. 2012;82(3):257-259.
25.
Katsuda Y, Kemmochi Y, Maki M, et al. Effects of unilateral nephrectomy on renal function in male
Spontaneously Diabetic Torii fatty rats: a novel obese type 2 diabetic model. J Diabetes Res.
2014;2014:363126.
26.
O'Sullivan J, Finnie SL, Teenan O, et al. Refining the Mouse Subtotal Nephrectomy in Male 129S2/SV
Mice for Consistent Modeling of Progressive Kidney Disease With Renal Inflammation and Cardiac
Dysfunction. Front Physiol. 2019;10:1365.
27.
Racanicchi IA, Oliveira AB, Barbieri RL, Delle H, Duarte Ida S, Leme PL. Experimental models of
renal dysfunction in female rats. Functional and histological aspects after unilateral nephrectomy or
ligation of right renal vein with kidney preservation. Acta Cir Bras. 2015;30(12):824-830.
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
24 / 30
28.
Heyman SN, Khamaisi M, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia response and
the progression of chronic kidney disease. American journal of nephrology. 2008;28(6):998-1006.
29.
Heyman SN, Khamaisi M, Zorbavel D, Rosen S, Abassi Z. Role of Hypoxia in Renal Failure Caused
by Nephrotoxins and Hypertonic Solutions. Seminars in nephrology. 2019;39(6):530-542.
30.
Heyman SN, Gorelik Y, Zorbavel D, et al. Near-drowning: new perspectives for human hypoxic acute
kidney injury. Nephrol Dial Transplant. 2020;35(2):206-212.
31.
Bobulescu IA. Renal lipid metabolism and lipotoxicity. Current opinion in nephrology and
hypertension. 2010;19(4):393-402.
32.
Afshinnia F, Nair V, Lin J, et al. Increased lipogenesis and impaired beta-oxidation predict type 2
diabetic kidney disease progression in American Indians. JCI insight. 2019;4(21).
33.
Katsuda Y, Kemmochi Y, Maki M, et al. Physiological changes induced by salt intake in female
Spontaneously Diabetic Torii-Lepr(fa) (SDT fatty) rat, a novel obese type 2 diabetic model. Animal
science journal = Nihon chikusan Gakkaiho. 2014;85(5):588-594.
34.
Saavedra JM. Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.
Clinical science. 2012;123(10):567-590.
35.
Villapol S, Saavedra JM. Neuroprotective effects of angiotensin receptor blockers. American journal of
hypertension. 2015;28(3):289-299.
36.
Baylis C, Corman B. The aging kidney: insights from experimental studies. J Am Soc Nephrol.
1998;9(4):699-709.
37.
Noshahr ZS, Salmani H, Khajavi Rad A, Sahebkar A. Animal Models of Diabetes-Associated Renal
Injury. J Diabetes Res. 2020;2020:9416419.
38.
Lee M, Sorn SR, Lee Y, Kang I. Salt Induces Adipogenesis/Lipogenesis and Inflammatory
Adipocytokines Secretion in Adipocytes. International journal of molecular sciences. 2019;20(1).
39.
Soler MJ, Riera M, Batlle D. New experimental models of diabetic nephropathy in mice models of type
2 diabetes: efforts to replicate human nephropathy. Exp Diabetes Res. 2012;2012:616313.
40.
Bhuiyan AS, Rafiq K, Kobara H, Masaki T, Nakano D, Nishiyama A. Effect of a novel nonsteroidal
selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal
injury in high salt-treated type 2 diabetic mice. Hypertension research : official journal of the Japanese
Society of Hypertension. 2019;42(6):892-902.
41.
Nishiyama A, Yoshizumi M, Rahman M, et al. Effects of AT1 receptor blockade on renal injury and
mitogen-activated protein activity in Dahl salt-sensitive rats. Kidney Int. 2004;65(3):972-981.
42.
Hinojosa-Laborde C, Jespersen B, Shade R. Physiology Lab Demonstration: Glomerular Filtration Rate
in a Rat. J Vis Exp. 2015(101):e52425.
43.
Sano R, Ishii Y, Yamanaka M, et al. Glomerular hyperfiltration with hyperglycemia in the
spontaneously diabetic Torii (SDT) fatty rat, an obese type 2 diabetic model. Physiol Res.
2021;70(1):45-54.
44.
Ellery SJ, Cai X, Walker DD, Dickinson H, Kett MM. Transcutaneous measurement of glomerular
filtration rate in small rodents: through the skin for the win? Nephrology (Carlton).
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
25 / 30
2015;20(3):117-123.
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
26 / 30
Figure 1
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
27 / 30
Figure 2
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
28 / 30
Figure 3
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
29 / 30
Figure 4
A Self-archived copy in
Kyoto University Research Information Repository
https://repository.kulib.kyoto-u.ac.jp
30 / 30
Figure 5
...
論文の公開元へ
